The Company Specializing in Artificial Intelligence
(AI)-based Discovery of Innovative Drug Delivery Vehicles and Drug Candidates

The Company Specializing in Artificial Intelligence
(AI)-based Discovery of Innovative Drug Delivery Vehicles and Drug Candidates

The Company Specializing in Artificial Intelligence
(AI)-based Discovery of Innovative Drug Delivery Vehicles and Drug Candidates

R&D

AI-based Innovation Discovery Platform

About AZothBio

The Company Specializing in AI-based Discovery of

Innovative Drug Delivery Vehicles and Drug Candidates

PIPELINE

Innovative Treatment

  • 01

    AZB101 (Autoimmune Disease Therapeutics)

    AZB101 is designed to selectively target and inhibit TYK2-JH2, a mechanism linked to numerous autoimmune diseases, such as psoriasis.

  • 02

    AZB102 (Solid Cancer Therapeutics)

    AZB102 is designed to selectively target and inhibit TRKA, a mechanism related to cancers positive for the NTRK fusion gene.

  • 03

    AZB201 (Nucleic Acid Delivery Vehicle)

    AZB201 has the property to form nano-sized particles by combining with nucleic acids and has the function to deliver the nucleic acids to the cell nucleus.

  • 04

    AZB301 (Tissue Regeneration Therapeutics)

    AZB301 is cell-permeable and specifically targets
    the endoplasmic reticulum within cells.